Previous Article | Next Article ![]()
Journal of Clinical Microbiology, 09 1997, 2320-2324, Vol 35, No. 9
R Ramani, A Ramani and SJ Wong
A rapid flow cytometric assay for in vitro antifungal drug susceptibility
testing was developed by adapting the proposed reference method for broth
macrodilution testing of yeasts. Membrane permeability changes caused by
the antifungal agent were measured by flow cytometry using propidium
iodide, a nucleic acid-binding fluorochrome largely excluded by the intact
cell membrane. We determined the in vitro susceptibility of 31 Candida
albicans isolates and two quality control strains (Candida parapsilosis
ATCC 22019 and Candida krusei ATCC 6258) to amphotericin B and fluconazole.
Amphotericin B MICs ranged from 0.03 to 2.0 microg/ml, while fluconazole
MICs ranged from 0.125 to 128 microg/ml. This method results in clear-cut
endpoints that were reproducible. Four-hour incubation was required for
fluconazole, whereas a 2-h incubation was sufficient for amphotericin B to
provide MICs comparable to the reference macrodilution method developed by
the National Committee for Clinical Laboratory Standards Subcommittee on
Antifungal Susceptibility Tests. Results of these studies show that flow
cytometry provides a rapid and sensitive in vitro method for antifungal
susceptibility testing of C. albicans.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
Rapid flow cytometric susceptibility testing of Candida albicans
Mycology Laboratory, Wadsworth Center, New York State Department of Health, Albany 12201-2002, USA. rxr15@health.state.ny.us
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|